{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:11518"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:11518","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Carbon nanotubes as delivery systems for chemotherapeutics in 2D and 3D cell models","abstract":"Despite significant advances in recent years, cancer remains a major worldwide health problem. Traditional chemotherapeutics are very potent, yet their administration is accompanied by severe adverse effects due to low specificity, as well as the development of resistance. Therefore, in efforts to improve the success of current therapies, nanomedicine has presented revolutionary approaches in the delivery of anticancer drugs. In this context, carbon nanotubes have emerged as a promising drug delivery system due to their unique structure and physicochemical properties, offering a wide variety of opportunities for biomedical applications. This thesis presents the development of novel anticancer therapeutic modalities through the integration of multi-walled carbon nanotubes (MWNTs) with the first-line antineoplastic agents cisplatin (CDDP) or doxorubicin (DOX). Thorough physicochemical characterisation of Pluronic-coated MWNTs, carboxyl- MWNTs and amine-MWNTs was performed to measure relevant aspects such as MWNT length, surface functionalisation and charge, concluding that the chemically functionalised MWNT were highly-dispersible and biocompatible. Furthermore, the anticancer activity of MWNTs + DOX and MWNTs + CDDP complexes was assessed on breast carcinoma (MCF7) 2D cells and 3D tumour spheroids, generated with a low-cost and reliable method. While the combination of MWNTs + DOX depicted a comparable efficacy of that observed with free DOX, MWNTs + CDDP complexes displayed a marked enhanced therapeutic efficacy compared to CDDP alone, resulting in higher cytotoxicity in monolayer 2D cultures as well as greater growth inhibition and even disaggregation of the 3D spheroids. Further analysis revealed that carboxylated MWNTs + CDDP complexes increased the intracellular accumulation of CDDP, leading to oxidative imbalance, cell cycle arrest and apoptosis induction. This work highlights the development of a promising therapeutic modality for the treatment of breast cancer that demonstrated to not only efficiently chemo-sensitise cancer cells to CDDP, but also enhance the anti-tumour efficacy in 2D and 3D cellular models.","abstract_html":"Despite significant advances in recent years, cancer remains a major worldwide health problem. Traditional chemotherapeutics are very potent, yet their administration is accompanied by severe adverse effects due to low specificity, as well as the development of resistance. Therefore, in efforts to improve the success of current therapies, nanomedicine has presented revolutionary approaches in the delivery of anticancer drugs. In this context, carbon nanotubes have emerged as a promising drug delivery system due to their unique structure and physicochemical properties, offering a wide variety of opportunities for biomedical applications. This thesis presents the development of novel anticancer therapeutic modalities through the integration of multi-walled carbon nanotubes (MWNTs) with the first-line antineoplastic agents cisplatin (CDDP) or doxorubicin (DOX). Thorough physicochemical characterisation of Pluronic-coated MWNTs, carboxyl- MWNTs and amine-MWNTs was performed to measure relevant aspects such as MWNT length, surface functionalisation and charge, concluding that the chemically functionalised MWNT were highly-dispersible and biocompatible. Furthermore, the anticancer activity of MWNTs + DOX and MWNTs + CDDP complexes was assessed on breast carcinoma (MCF7) 2D cells and 3D tumour spheroids, generated with a low-cost and reliable method. While the combination of MWNTs + DOX depicted a comparable efficacy of that observed with free DOX, MWNTs + CDDP complexes displayed a marked enhanced therapeutic efficacy compared to CDDP alone, resulting in higher cytotoxicity in monolayer 2D cultures as well as greater growth inhibition and even disaggregation of the 3D spheroids. Further analysis revealed that carboxylated MWNTs + CDDP complexes increased the intracellular accumulation of CDDP, leading to oxidative imbalance, cell cycle arrest and apoptosis induction. This work highlights the development of a promising therapeutic modality for the treatment of breast cancer that demonstrated to not only efficiently chemo-sensitise cancer cells to CDDP, but also enhance the anti-tumour efficacy in 2D and 3D cellular models.","abstract_has_math":false,"creators":["Ledezma Gallegos, Fabricio Noel"],"institution":"University of Birmingham","degree_name":"d_ph","degree_level":"d_ph","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2021,"date_issued":"2021-07","date_published":"2021-07","updated_at":"2026-11-19T09:31:25Z","subjects":["RM Therapeutics. Pharmacology"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.grantnumber","label":"Dc Identifier Grantnumber","values":["CONACyT Beca al extranjero"],"render_values":[{"text":"CONACyT Beca al extranjero","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/11518/1/LedezmaGallegos2021PhD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A11518","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["other"]},{"key":"dc:creator","label":"Author","values":["Ledezma Gallegos, Fabricio Noel"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2021-07"]},{"key":"dc:date.issued","label":"Date","values":["2021-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","School of Pharmacy"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/11518/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_ph"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_ph"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["RM Therapeutics. Pharmacology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.grantnumber","label":"Dc Identifier Grantnumber","values":["CONACyT Beca al extranjero"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/11518/1/LedezmaGallegos2021PhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Despite significant advances in recent years, cancer remains a major worldwide health problem. Traditional chemotherapeutics are very potent, yet their administration is accompanied by severe adverse effects due to low specificity, as well as the development of resistance. Therefore, in efforts to improve the success of current therapies, nanomedicine has presented revolutionary approaches in the delivery of anticancer drugs. In this context, carbon nanotubes have emerged as a promising drug delivery system due to their unique structure and physicochemical properties, offering a wide variety of opportunities for biomedical applications. This thesis presents the development of novel anticancer therapeutic modalities through the integration of multi-walled carbon nanotubes (MWNTs) with the first-line antineoplastic agents cisplatin (CDDP) or doxorubicin (DOX). Thorough physicochemical characterisation of Pluronic-coated MWNTs, carboxyl- MWNTs and amine-MWNTs was performed to measure relevant aspects such as MWNT length, surface functionalisation and charge, concluding that the chemically functionalised MWNT were highly-dispersible and biocompatible. Furthermore, the anticancer activity of MWNTs + DOX and MWNTs + CDDP complexes was assessed on breast carcinoma (MCF7) 2D cells and 3D tumour spheroids, generated with a low-cost and reliable method. While the combination of MWNTs + DOX depicted a comparable efficacy of that observed with free DOX, MWNTs + CDDP complexes displayed a marked enhanced therapeutic efficacy compared to CDDP alone, resulting in higher cytotoxicity in monolayer 2D cultures as well as greater growth inhibition and even disaggregation of the 3D spheroids. Further analysis revealed that carboxylated MWNTs + CDDP complexes increased the intracellular accumulation of CDDP, leading to oxidative imbalance, cell cycle arrest and apoptosis induction. This work highlights the development of a promising therapeutic modality for the treatment of breast cancer that demonstrated to not only efficiently chemo-sensitise cancer cells to CDDP, but also enhance the anti-tumour efficacy in 2D and 3D cellular models."]},{"key":"dc:format","label":"Dc Format","values":["text"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Carbon nanotubes as delivery systems for chemotherapeutics in 2D and 3D cell models"]}]}],"canonical_facts":{"dc:contributor.sponsor":["other"],"dc:creator":["Ledezma Gallegos, Fabricio Noel"],"dc:date":["2021-07"],"dc:date.issued":["2021-07"],"dc:description.abstract":["Despite significant advances in recent years, cancer remains a major worldwide health problem. Traditional chemotherapeutics are very potent, yet their administration is accompanied by severe adverse effects due to low specificity, as well as the development of resistance. Therefore, in efforts to improve the success of current therapies, nanomedicine has presented revolutionary approaches in the delivery of anticancer drugs. In this context, carbon nanotubes have emerged as a promising drug delivery system due to their unique structure and physicochemical properties, offering a wide variety of opportunities for biomedical applications. This thesis presents the development of novel anticancer therapeutic modalities through the integration of multi-walled carbon nanotubes (MWNTs) with the first-line antineoplastic agents cisplatin (CDDP) or doxorubicin (DOX). Thorough physicochemical characterisation of Pluronic-coated MWNTs, carboxyl- MWNTs and amine-MWNTs was performed to measure relevant aspects such as MWNT length, surface functionalisation and charge, concluding that the chemically functionalised MWNT were highly-dispersible and biocompatible. Furthermore, the anticancer activity of MWNTs + DOX and MWNTs + CDDP complexes was assessed on breast carcinoma (MCF7) 2D cells and 3D tumour spheroids, generated with a low-cost and reliable method. While the combination of MWNTs + DOX depicted a comparable efficacy of that observed with free DOX, MWNTs + CDDP complexes displayed a marked enhanced therapeutic efficacy compared to CDDP alone, resulting in higher cytotoxicity in monolayer 2D cultures as well as greater growth inhibition and even disaggregation of the 3D spheroids. Further analysis revealed that carboxylated MWNTs + CDDP complexes increased the intracellular accumulation of CDDP, leading to oxidative imbalance, cell cycle arrest and apoptosis induction. This work highlights the development of a promising therapeutic modality for the treatment of breast cancer that demonstrated to not only efficiently chemo-sensitise cancer cells to CDDP, but also enhance the anti-tumour efficacy in 2D and 3D cellular models."],"dc:format":["text"],"dc:identifier.grantnumber":["CONACyT Beca al extranjero"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/11518/1/LedezmaGallegos2021PhD.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","School of Pharmacy"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/11518/"],"dc:subject":["RM Therapeutics. Pharmacology"],"dcterms:accessrights":["public"],"dc:title":["Carbon nanotubes as delivery systems for chemotherapeutics in 2D and 3D cell models"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_ph"],"dc:type.qualificationname":["d_ph"]},"updated_at":"2026-11-19T09:31:25Z"}